Aspirin Timing After Thrombolysis
Aspirin should be administered 24 hours after thrombolytic therapy in patients with acute ischemic stroke. 1
Guideline Recommendation
The 2018 AHA/ASA guidelines provide a Class I, Level A recommendation that aspirin administration in acute ischemic stroke patients should occur within 24 to 48 hours after onset. For patients treated with IV alteplase (tPA), aspirin administration is generally delayed until 24 hours later. 1 This represents the strongest evidence-based recommendation and should guide clinical practice.
The 2013 guidelines similarly state that initiation of anticoagulant or antiplatelet therapy within 24 hours of IV rtPA treatment is not recommended (Class III, Level B). 2
Why 24 Hours?
The rationale for this timing is based on:
- Bleeding risk: Early aspirin administration (<24 hours) significantly increases symptomatic intracranial hemorrhage (SICH) risk
- Lack of benefit: No improvement in functional outcomes at 3 months when aspirin is given early
Evidence Against Earlier Administration
The ARTIS trial (2012) provides the most definitive evidence against early aspirin use. This randomized controlled trial of 642 patients compared IV aspirin given within 90 minutes of alteplase versus standard treatment (aspirin at 24 hours). The trial was terminated prematurely due to:
- Increased SICH: 4.3% in early aspirin group vs 1.6% in standard treatment (p=0.04) 3
- No benefit: No improvement in favorable outcomes (54.0% vs 57.2%, p=0.42) 3
- Worse outcomes from bleeding: SICH was more often the cause of poor outcome in the aspirin group (11 vs 1 patient, p=0.006) 3
A 2014 post-hoc analysis confirmed that aspirin increased early neurological deterioration due to SICH (OR 3.73,95% CI 1.03-13.49) without reducing ischemic deterioration. 4
Recent Observational Data
While a 2024 retrospective study suggested that aspirin at 18-21 hours might be safe (only 1 bleed in >24 hour group, none in earlier group), 5 this contradicts the higher-quality randomized trial evidence and should not change practice. Observational studies are subject to selection bias and lack the rigor to override guideline recommendations based on randomized controlled trials.
Exception to the Rule
The guidelines note that aspirin might be considered before 24 hours "in the presence of concomitant conditions for which such treatment given in the absence of IV alteplase is known to provide substantial benefit or withholding such treatment is known to cause substantial risk." 1 However, this is a narrow exception requiring compelling alternative indications.
Clinical Algorithm
- Standard practice: Wait 24 hours after alteplase before starting aspirin
- Dose: 160-300 mg based on trial evidence (though specific dosing recommendation was removed from 2018 guidelines) 1
- Route: Oral preferred; rectal or nasogastric if unable to swallow 1
- Timing window: Between 24-48 hours after stroke onset 1
Common Pitfall
Do not give aspirin early (<24 hours) thinking it will prevent reocclusion or improve outcomes. The evidence clearly shows this increases hemorrhagic complications without clinical benefit. The modest benefit of aspirin in acute stroke comes primarily from preventing recurrent events, not from limiting the initial stroke itself. 2